OptiBiotix Health (LON:OPTI) Stock Price Up 13.3% – Should You Buy?

OptiBiotix Health Plc (LON:OPTI) shares shot up 13.3% on Thursday . The company traded as high as GBX 6.74 and last traded at GBX 6.74. 676,800 shares were traded during trading, an increase of 93% from the average daily volume of 350,658 shares. The stock had previously closed at GBX 5.95.

OptiBiotix Health Price Performance

The company has a 50 day moving average of GBX 5.79 and a two-hundred day moving average of GBX 5.73. The company has a market capitalization of £6.96 million, a PE ratio of -1.76 and a beta of 1.82.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.